Remove 2023 Remove Complication Remove Diabetes Remove Management
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. The study was terminated early because benefits were already significantly visible by October 2023. semaglutide 1.0 mg or placebo in 2019. mg is not recommended. mg is not recommended.

Diabetes 130
article thumbnail

Navigating the Quademic: Clinical Differentiation of Influenza, RSV, COVID-19, and Norovirus in Pediatric Emergency Care

PEMBlog

Differentiating these pathogens based on clinical presentation is crucial for targeted management, minimizing unnecessary diagnostic tests, and optimizing healthcare resources. Common Complications : Otitis media : Diagnosis is supported by the presence of a bulging tympanic membrane with purulent effusion.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chronic disease management among people with serious mental illness across rural, small urban, and metropolitan settings [Health care disparities]

Annals of Family Medicine

Context: People with serious mental illness (SMI) are at increased risk of complications and earlier death from comorbid chronic diseases, compared with patients without mental illness. These disparities may be related to differences in access to recommended chronic disease management.

article thumbnail

When to Go to Urgent Care for a Sore Throat: How Can Urgent Care Help?

Doctor On Demand

However, there are “Red Flag” symptoms that require urgent evaluation and management. A doctor can help identify triggers, suggest lifestyle changes, and recommend medications to manage symptoms. Infections or allergic reactions can block your airway and lead to life-threatening complications.

ER 52
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. Share Tweet Share Email Home Psychology & Psychiatry Home Addiction June 16, 2025 The GIST Texas invests $50M in psychedelic drug research to treat addiction by I.